Pacira Pharmaceuticals

Pacira Pharmaceuticals presents phase I results

Wednesday, March 9, 2011

Pacira Pharmaceuticals announced positive results from its phase I study evaluating Exparel (bupivacaine extended-release liposome injection) in patients with moderate hepatic impairment.  The results were presented at the 2011 American Society for Clinical Pharmacology and Therapeutics (ASCPT) 112th Annual Meeting in Dallas, Texas.

[Read More]